| Serial Number | 78802619 |
| Word Mark | VERENTA PHARMACEUTICALS |
| Filing Date | Monday, January 30, 2006 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Thursday, December 27, 2007 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, April 3, 2007 |
| Indication of Colors claimed | The color(s) black and blue is/are claimed as a feature of the mark. |
| Description of the Colors Claimed | The colors black and blue appear in the triangle mark with check-mark and the wording VERENTA PHARMACEUTICALS is in black. The color "white" is intended to be transparent. |
| Disclaimer with Predetermined Text | "PHARMACEUTICALS" |
| Goods and Services | Anti-diabetic pharmaceuticals; Antibacterial pharmaceuticals; Antimicrobial preparations for inhibiting microbiological decomposition in food, beverages, animal feed and pharmaceuticals; Astringents; Cardiovascular pharmaceuticals; Dermatological pharmaceutical products; Drug delivery agents consisting compounds that facilitate delivery of a wide range of pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers filled with prodrugs, steroids, beta-agonists, anti- inflammatories or combinations thereof; Injectable pharmaceuticals for treatment of anaphylactic reactions; Ocular pharmaceuticals; Pharmaceutical anti-allergic preparations and substances; Pharmaceutical antitussive-cold preparations; Pharmaceutical for the treatment of erectile dysfunction; Pharmaceutical preparation for the treatment of gout; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for animal skincare; Pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; Pharmaceutical preparations for ocular or intraocular surgery; Pharmaceutical preparations for the treatment of heart rhythm disorders; Pharmaceutical preparations for the treatment of hormonal disorders and the prevention of osteoporosis; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of diseases; Pharmaceutical preparations for treating allergic rhinitis and asthma; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical preparations for wounds; Pharmaceutical preparations namely, anticoagulants; Pharmaceutical preparations namely, antidepressants; Pharmaceutical preparations namely, appetite suppressants; Pharmaceutical preparations, namely, a drug delivery system comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents; Pharmaceutical products and preparations against dry skin caused by pregnancy; Pharmaceutical products and preparations for chloasma; Pharmaceutical products and preparations for hydrating the skin during pregnancy; Pharmaceutical products and preparations for pregnancy blemishes; Pharmaceutical products and preparations for preventing skin blemishes during pregnancy; Pharmaceutical products and preparations to prevent stretch marks; Pharmaceutical products and preparations to prevent swelling in the legs; Pharmaceutical products for ophthalmological use; Pharmaceutical products for skin care for animals; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical skin lotions; Pharmaceutical solutions used in dialysis; Pharmaceuticals for the treatment of erectile dysfunction; Pharmaceuticals, namely, anti-infectives; Pharmaceuticals, namely, antihelmintics; Pharmaceuticals, namely, inducers of erections; Pharmaceuticals, namely, lipid lowering agents; Pharmaceuticals, namely, psychotropics; Plant extracts for medical, veterinary and pharmaceutical purposes; Potassium preparations for pharmaceutical purposes; Synthetic peptides for pharmaceutical purposes; Unit dose capsules sold empty for pharmaceutical use; Vitamin and mineral preparations for use as ingredients in the food and pharmaceutical industry |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 3, 2006 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Verenta Pharmaceuticals, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Lenexa, KS 66214 |
| Party Name | Verenta Pharmaceuticals, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Lenexa, KS 66214 |
| Event Date | Event Description |
| Wednesday, March 5, 2008 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED |
| Wednesday, March 5, 2008 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, June 26, 2007 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, April 27, 2007 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Friday, April 27, 2007 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, April 3, 2007 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 14, 2007 | NOTICE OF PUBLICATION |
| Friday, February 16, 2007 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Friday, February 16, 2007 | EXAMINER'S AMENDMENT ENTERED |
| Friday, February 16, 2007 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, February 16, 2007 | EXAMINER'S AMENDMENT ENTERED |
| Friday, February 16, 2007 | EXAMINERS AMENDMENT E-MAILED |
| Friday, February 16, 2007 | EXAMINERS AMENDMENT -WRITTEN |
| Sunday, February 11, 2007 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Monday, January 22, 2007 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Wednesday, December 27, 2006 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, December 27, 2006 | ASSIGNED TO LIE |
| Friday, December 8, 2006 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, December 8, 2006 | EXAMINER'S AMENDMENT ENTERED |
| Friday, December 8, 2006 | EXAMINERS AMENDMENT E-MAILED |
| Friday, December 8, 2006 | EXAMINERS AMENDMENT -WRITTEN |
| Friday, December 8, 2006 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Friday, December 8, 2006 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Sunday, November 19, 2006 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Friday, October 27, 2006 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Thursday, October 12, 2006 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Friday, October 6, 2006 | ASSIGNED TO LIE |
| Wednesday, October 4, 2006 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, October 4, 2006 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, October 4, 2006 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, October 4, 2006 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, October 4, 2006 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, September 27, 2006 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, September 14, 2006 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, September 14, 2006 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, July 24, 2006 | NON-FINAL ACTION E-MAILED |
| Monday, July 24, 2006 | NON-FINAL ACTION WRITTEN |
| Wednesday, July 19, 2006 | ASSIGNED TO EXAMINER |
| Saturday, February 4, 2006 | NOTICE OF DESIGN SEARCH CODE MAILED |
| Friday, February 3, 2006 | NEW APPLICATION ENTERED IN TRAM |